← All trials
NCT04780152
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2021
- Primary completion
- Aug 31, 2022
- Completion date
- Sep 30, 2022
- First posted
- Mar 3, 2021
- Last posted
- Jun 4, 2021
- Enrollment
- 172
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco SuarezLead sponsor
- El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco SuarezReponsible party - principal investigator
- Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, MexicoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.